ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,061, issued on March 17, was assigned to OSAKA UNIVERSITY (Osaka, Japan).
"Agent for inducing regression of triglyceride deposit atherosclerosis" was invented by Ken-ichi Hirano (Osaka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an agent for inducing regression of triglyceride (TG) deposit atherosclerosis, which agent comprises tricaprin/trisdecanoin as an active ingredient, an agent for improving blood flow in a patient with TG deposit atherosclerosis, which agent comprises tricaprin/trisdecanoin as an active ingredient, and a pharmaceutical or food or drink product comprising the agent for inducing regress...